Chemosensitization effects of XIAP downregulation in K562 leukemia cells

Journal of Chemotherapy

Volumn 18, Issue 1, 2006, Pages 98-102

  Lima, R T ^a   Martins, L M ^b   Guimaraes J E ^a,c   Sambade, C ^a,c   Vasconcelos, M Helena ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c University of Porto   (Portugal)

Author keywords

Antisense; Apoptosis; Chemosensitization; CML; xIAP

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DOXORUBICIN; ETOPOSIDE; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN K 562; CELL VIABILITY; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PROTEIN EXPRESSION;

EID: 33645103808     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.1.98     Document Type: Article

References (20)

1. Igney FH, Krammer PH. Death and the anti-death: tumour resistance to apoptosis. Nat Rev Cancer 2002; 2, 277-288
2. Cory J, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2002; 2(9):647-656.
3. Holcik M, Korneluk RG. XIAP, the guardian angel. Nat Rev Mol Cell Biol. 2001;2(7):550-556
4. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol. 2002; 3: 401-410.
5. Sasaki H, Sheng Y, Kotsuji F, Tsang BK. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res. 2000; 60: 5659-5666.
6. Hu Y, Cherton-Horvat G, Dragowska V et al. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res. 2003; 9(7): 2826-2836.
7. Amantana A, London CA, Iversen PL, Devi GR. X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 2004;3(6): 699-707.
8. Lima RT, Martins LM, Guimarães JE, Sambade C, Vasconcelos MH. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells. Cancer Gene Therapy. 2004; 11: 309-316.
9. McManus DC, Lefebvre CA, Cherton-Horvat G et al. Loss of XIAP protein expression by RNAi and antisense approaches sensitizes cancer cells to functionally diverse chemotherapeutics. Oncogene. 2004; 23(49):8105-8117.
10. Tong QS, Zheng LD, Wang L et al. Downregulation of XIAP expression induces apoptosis and enhances chemotherapeutic sensitivity in human gastric cancer cells. Cancer Gene Ther. 2005; 12(5): 509-514.
11. Schimmer AD, Welsh K, Pinilla C et al. Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell. 2004;5(1): 25-35.
12. Carter BZ, Milella M, Tsao T et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia. 2003; 17: 2081-2089.
13. Hersey P, Zhang XD. How melanoma cells evade trail-induced apoptosis. Nature Rev Cancer. 2001; 1: 142-150.
14. Vasconcelos MH, Beleza SS, Quirk C, Maia LF, Sambade C, Guimaraes JE. Limited synergistic effect of antisense oligonucleotides against bcr-abl and transferrin receptor mRNA in leukemic cells in culture. Cancer Lett. 2000; 152(2): 135-143.
15. Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y. Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and the therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer. 2003; 103: 29-37.
16. Meng RD, Phillips P, El-Deiry WS. P53- independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int J Oncol. 1999; 14(1):5-14.
17. Ma Y, Yuan R, Meng Q, Goldberg ID, Rosen EM, Fan S. P53-independent down-regulation of Mdm2 in human cancer cells treated with adriamycin. Mol Cell Biol Res Commmun. 2000; 3(2): 122-128.
18. Jin S, Kalkum M, Overholtzer M, Stoffel A, Chait BT, Levine AJ. CIAP1 and the serine protease HTRA2 are involved in a novel p53-dependent apoptosis pathway in mammals. Genes Dev. 2003;17(3):359-367.
19. Lorenzo E, Ruiz-Ruiz C, Quesada AJ et al. Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism. J Biol Chem. 2002; 277(13): 10883-10892.
20. Wang S, Konorev EA, Kotamraju S, Joseph J, Kalivendi S, Kalyanaraman B. Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms, intermediacy of H(2)O(2)- and p53-dependent pathways. J Biol Chem. 2004;279(24):25535-25543.